Does HER2 immunoreactivity provide prognostic information in locally advanced urothelial carcinoma patients receiving adjuvant M-VEC chemotherapy?

Yuh-Shyan Tsai, Tzong Shin Tzai, Nan-Haw Chow

Research output: Contribution to journalArticlepeer-review

22 Citations (Scopus)

Fingerprint Dive into the research topics of 'Does HER2 immunoreactivity provide prognostic information in locally advanced urothelial carcinoma patients receiving adjuvant M-VEC chemotherapy?'. Together they form a unique fingerprint.

Medicine & Life Sciences